Objective To evaluate the clinical value of postreatment plasmatic levels of the squamous
cell carcinoma antigen (SCC-Ag) as a survival independent prognostic factor in patients with …

Objective The aim of this study was to assess the potential benefit of routine squamous cell
carcinoma antigen (SCC-Ag) assessment during follow-up of patients after treatment for …

Objective: The aim of the present study was to assess prognostic factors for patients with
locally advanced cervical cancer treated with radiotherapy as the primary treatment and to …

Objective To analyze the association between posttreatment squamous cell carcinoma
antigen (SCC Ag) and treatment failure in patients with cervical SCC treated with concurrent …

Objective: To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag)
levels upon the diagnosis of recurrent cervical cancer for decision making in patient …

PURPOSE To investigate the prognostic value of pretreatment serum squamous cell
carcinoma antigen (SCC-ag) levels in patients with cervical squamous cell carcinoma in …

Objective Neoadjuvant chemotherapy (NACT) could affect the levels of squamous cell
carcinoma antigen (SCC-Ag). This study evaluates the predictive value of pre-and …

Results: As the FIGO stage increases, mean pre-treatment SCC Ag also increases. Node-
positive patients had higher pre-treatment SCC Ag as compared to those who were negative …

Objective: We investigated the role of squamous cell carcinoma (SCC) at presentation (pre-
SCC) and after treatment (post-SCC) as predictor of pathological response and outcome in …

Objective The aim of this systematic review and meta-analysis was to pool association
effects of serum squamous cell carcinoma antigen (SCC-Ag) on recurrence and mortality in …